For three decades, our faculty have engaged in innovative research and clinical efforts to develop novel treatments for opioid-use disorder. Our work began with the seminal studies demonstrating buprenorphine (BUP) treatment efficacy, which contributed to its FDA approval.
Surveillance & Evaluation Core
Best Practices Core
Clinician Advisory Board
John Brooklyn, M.D.
Associate Clinical Professor of Family Medicine, Medicine and Psychiatry, UVM Larner College of Medicine
Sanchit Maruti, M.D., M.S.
Assistant Professor of Psychiatry, UVM Larner College of Medicine
Education & Outreach Core
This publication is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $10,365,921 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.